Serge Belanger
Stock Analyst at Needham
(4.62)
# 214
Out of 5,240 analysts
419
Total ratings
56.27%
Success rate
24.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCS Oculis Holding AG | Maintains: Buy | $40 → $46 | $31.15 | +47.67% | 4 | May 12, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Buy | $25 → $30 | $18.31 | +63.89% | 17 | May 12, 2026 | |
| LQDA Liquidia | Maintains: Buy | $54 → $70 | $56.69 | +23.48% | 37 | May 11, 2026 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $80 → $78 | $55.42 | +40.76% | 16 | May 8, 2026 | |
| AMPH Amphastar Pharmaceuticals | Downgrades: Hold | n/a | $18.36 | - | 10 | May 8, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterates: Buy | $36 | $21.83 | +64.91% | 26 | May 7, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $18 → $16 | $9.61 | +66.49% | 19 | May 6, 2026 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $24 → $23 | $15.58 | +47.63% | 24 | May 6, 2026 | |
| CYTK Cytokinetics | Maintains: Buy | $85 → $102 | $75.87 | +34.44% | 28 | May 5, 2026 | |
| VRDN Viridian Therapeutics | Reiterates: Buy | $32 | $17.07 | +87.51% | 22 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.13 | - | 22 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $32 | $22.93 | +39.56% | 30 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $26.84 | - | 26 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $7.58 | +97.89% | 22 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54 → $56 | $35.07 | +59.68% | 29 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $9.27 | +94.17% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $37.42 | +28.27% | 11 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $6.58 | - | 17 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.75 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.94 | +219.01% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.08 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.18 | - | 1 | Mar 31, 2022 |
Oculis Holding AG
May 12, 2026
Maintains: Buy
Price Target: $40 → $46
Current: $31.15
Upside: +47.67%
MoonLake Immunotherapeutics
May 12, 2026
Maintains: Buy
Price Target: $25 → $30
Current: $18.31
Upside: +63.89%
Liquidia
May 11, 2026
Maintains: Buy
Price Target: $54 → $70
Current: $56.69
Upside: +23.48%
Xenon Pharmaceuticals
May 8, 2026
Maintains: Buy
Price Target: $80 → $78
Current: $55.42
Upside: +40.76%
Amphastar Pharmaceuticals
May 8, 2026
Downgrades: Hold
Price Target: n/a
Current: $18.36
Upside: -
Arcutis Biotherapeutics
May 7, 2026
Reiterates: Buy
Price Target: $36
Current: $21.83
Upside: +64.91%
BioCryst Pharmaceuticals
May 6, 2026
Maintains: Buy
Price Target: $18 → $16
Current: $9.61
Upside: +66.49%
Trevi Therapeutics
May 6, 2026
Maintains: Buy
Price Target: $24 → $23
Current: $15.58
Upside: +47.63%
Cytokinetics
May 5, 2026
Maintains: Buy
Price Target: $85 → $102
Current: $75.87
Upside: +34.44%
Viridian Therapeutics
May 5, 2026
Reiterates: Buy
Price Target: $32
Current: $17.07
Upside: +87.51%
May 4, 2026
Downgrades: Hold
Price Target: n/a
Current: $3.13
Upside: -
May 1, 2026
Maintains: Buy
Price Target: $30 → $32
Current: $22.93
Upside: +39.56%
Apr 30, 2026
Downgrades: Hold
Price Target: n/a
Current: $26.84
Upside: -
Apr 27, 2026
Maintains: Buy
Price Target: $14 → $15
Current: $7.58
Upside: +97.89%
Mar 19, 2026
Reiterates: Buy
Price Target: $54 → $56
Current: $35.07
Upside: +59.68%
Feb 20, 2026
Maintains: Buy
Price Target: $20 → $18
Current: $9.27
Upside: +94.17%
Feb 18, 2026
Maintains: Buy
Price Target: $46 → $48
Current: $37.42
Upside: +28.27%
Dec 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.58
Upside: -
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.75
Upside: -
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.94
Upside: +219.01%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.08
Upside: -
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.18
Upside: -